agilon health, inc.

NYSE:AGL

3.87 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operating Activities:
Net Income -30.6823.217-167.088-31.483-16.79515.959-56.549-30.739-20.7311.155-56.737-35.958-298.941-15.151-24.215-11.827-7.911-16.099-149.311
Depreciation & Amortization 5.9075.8444.7355.315.5154.1893.9073.453.0423.3733.6383.9373.6143.4813.7533.5013.4823.363-25.825
Deferred Income Tax 0.41700.2671.211.073066.728000-3.2310.452-2.1281.186-23.1770.347-0.3800
Stock Based Compensation 18.20716.90915.51520.73619.57213.6729.9517.9076.5533.974.41411.96274.5481.4721.771.6162.2311.0710.919
Change In Working Capital -3.977-63.33595.6236.267-20.487-91.470.18216.951-46.314-30.254-7.4022.588-16.629-33.58225.7352.512-6.476-15.29925.167
Accounts Receivables 000000-204.167000-149.041000-59.3810000
Change In Inventory 000000204.167000000000000
Change In Accounts Payables 0032.11100065.73600019.3600000000
Other Working Capital -3.977-63.33595.6236.267-20.487-91.47-65.55416.951-46.314-30.254-26.7622.588-16.629-33.58225.7352.512-6.476-15.29925.167
Other Non Cash Items 21.84918.186-10.218-15.058-10.082-3.161-74.1785.078-2.813-1.47710.421-2.1220.2451.7662.795-0.516-0.3170.837120.913
Operating Cash Flow -18.717-47.776-61.166-13.018-21.204-60.811-49.9592.647-60.263-23.233-48.897-19.143-39.291-40.828-13.339-4.367-9.371-26.127-28.137
Investing Activities:
Investments In Property Plant And Equipment -9.767-14.577-15.382-5.785-5.931-3.717-8.309-3.68-15.623-5.049-3.468-5.294-0.5-4.164-0.56-0.543-0.869-0.378-0.694
Acquisitions Net 001.42-0.112-1.837-44.367-0.5-10.8480.50.51.301.062-3.70624.381.825000
Purchases Of Investments -12.0060-7.637-41.452-35.599-29.969-35.082-138.106-285.077-0.683000000000
Sales Maturities Of Investments 41.22474.52330.14636.62568.72928.5437.42110.8483.5960.683000000000
Other Investing Activites -1.234-8.508-10.75-0.31-5.33-1.301-1.510.848-0.007-4.32-0.435-6.271-67.826-1.204-0.546-0.139-1.8010.697-0.314
Investing Cash Flow 18.21751.438-2.203-11.03420.032-50.814-7.97-130.938-296.611-8.869-2.603-11.565-67.264-9.07423.2741.143-2.670.319-1.008
Financing Activities:
Debt Repayment -1.25-1.25-1.25-1.25-1.25-1.25-1.25-1.25-1.25-1.25-1.252-0.001-49.999-31.351-0.76-0.761-0.76-0.76-0.76
Common Stock Issued -0.4641.8090.4052.66-0.7879.5892.3810.3615.55914.75616.481.0551,171.3280.16500.8634.59928.1280
Common Stock Repurchased -0.46400.7870-2000000000000-6.742000
Dividends Paid 0000000000000000000
Other Financing Activities 00.559-1.6321.41-1.259.5891.139.1114.30914.75611.6690.8951,162.778-1.0530-6.2430.31528.128105.024
Financing Cash Flow -1.7140.559-0.8451.41-202.0378.3391.139.1114.30913.50610.4170.8961,112.77930.298-0.76-6.1414.15427.368104.264
Other Information:
Effect Of Forex Changes On Cash 00-145.59218.415212.57400000-9.36500000000
Net Change In Cash -2.2144.221-64.214-22.642-203.209-103.286-56.799-119.18-352.565-18.596-41.083-29.8121,006.224-19.6049.175-9.365-7.8871.5675.119
Cash At End Of Period 116.336118.55114.329178.543201.185404.394507.68564.479683.6591,036.2241,054.821,095.9031,125.715119.491139.095129.92139.285147.17275.119